Metrics cut 1
- Capital requirement: revised down to under $20 million (from ~$25 million)
Event Participants
Executives
3 Ajay Agarwal, Ishaan Khanna, Rajit Mehta
Analysts
5 Harsh Kundnani, Nikhil Gupta, Rajveer Singh, Ranodeep S., Vikas
Financials & KPIs
| Metric | Reported | Commentary |
|---|---|---|
| Consolidated Revenue | ₹68.6 crores | +66% YoY from ₹41.3 crores; marginally down QoQ due to lumpy DMP income timing |
| Consolidated EBITDA Loss | ₹25 crores | vs ₹23.2 crores Q1 FY26 and ₹6.8 crores Q4 FY26; decline attributed to exceptional DMP receipt in previous quarter |
| Consolidated Net Worth | ₹372 crores | As of June 30, 2026 |
| Treasury Assets (MAXIND) | ₹21 crores | As of June 30, 2026 |
| Antara Noida Possession Demand | ₹169 crores | Raised with offer of possession to all 340 residents; ~75% collected as of August |
| Antara Noida Phase 2 Pricing | ₹16,000-18,000+ per sq ft | vs ₹7,000-11,000 per sq ft in Phase 1; profit realization expected on Phase 2 launch |
| Gurgaon 360 Collection | ₹42.5 crores (Q1) | ITD collections at ₹556 crores; 87% collection efficiency since inception |
| Gurgaon 360 Management Fee | ₹47.69 crores | ₹3 crores accrued in Q1 FY27 |
| Gurgaon 361 Bookings | 154 units of 360 | 27 units sold in Q1; July sales recovered to 34 units; total collections ₹108.2 crores |
| Dehradun Operating Revenue | ₹6.2 crores | 1.1x YoY, marginally down ₹7 lakhs due to cyclical club membership; operating profit ₹0.92 crores (2.3x YoY) |
| Dehradun Re-lease Marketing Fee | ₹1.9 crores | From 4 re-leased units |
| Care Homes & Services Revenue | ₹12.03 crores | 1.5x YoY; 1.1x QoQ; served 2,700 patients in Q1, 53,000 total since inception |
| Occupied Bed Days (OBD) Growth | +23% QoQ | Occupancy improving across care homes |
| Care Home Occupancy Rates | Bannerghatta 41%, Gurugram 41%, Whitefield 18%, OMR 12% | Up from 37%, 33%, 8%, and 3% respectively in Q4 FY26 |
| RPOB (Revenue per Occupied Bed) | ₹7,000+ | 4 care homes achieved highest-ever RPOB in June 2026; blended expected near ₹7,500 |
| AGZ Net Revenue | ₹19 crores | 1.3x YoY; down from ₹23 crores QoQ due to post-Q4 peak moderation |
| AGZ ARR | ~₹120 crores | Monthly run rate ~₹10 crores in July (marketplaces ₹6 crores, D2C ₹3.8 crores) |
| AGZ Gross Margin (Online) | 45% | vs 46% prior quarter despite COGS pressure from geopolitical situation |
| AGZ ROAS | 2.0 exit Q1 | Up from 1.8 in Q4; D2C exit ROAS 2.6; marketplaces CM2 improved to -17% |
| AGZ Conversion Rate | 3.5% | Up from 2% |
| AGZ Product Portfolio | 112 launched, 86 live | 4 patents granted, 3 filed; unique diaper selling 1,500 packs/day; 6x market share growth on Amazon in 60 days |
| AGZ Customer Base | 9 lakh lives touched | 88,000 repeat customers; 82% SAT index; NPS of 60 |
| AIWC Net Revenue | ₹15.75 lakhs | Negative contribution margin expected initially; 96% customer satisfaction; sessions up from 199 to 307 in June |
| Capital Requirement | ~$20 million | Revised down from $25 million; second fund raise pushed out due to better performance and Noida collections |
Geographic & Segment Commentary
Antara Senior Living (Residences): Noida community achieved major milestone with possession offered to all 340 residents in June 2026; ₹169 crores demand raised, 75% collected. Dehradun remains profitable with stable occupancy. Gurgaon 360 fully sold out; 361 launched 360 units with 154 booked, sales velocity recovered in July. Focus shifting to Phase 2 approvals in Noida for profit realization at ₹16,000-18,000+ per sq ft. Expansion targets include Bangalore (300 units, ~₹900 crores value) and Dehradun (<150 units, ₹850-900 crores value) for 1.5 million sq ft ambition.
Antara Assisted Care (Care Homes & Services): All 8 care homes operational across NCR, Bengaluru, and Chennai with 485 beds. Five of eight trending per operating model; occupancy steadily improving across Bannerghatta (41%), Gurugram (41%), Whitefield (18%), and OMR (12%). Revenues rose 1.5x YoY to ₹12.03 crores. Four care homes achieved highest-ever RPOB of ₹7,000+ in June. New bed expansion expected post October-November inflection point, with capex of ₹10-12 lakhs per bed.
Antara Gen Z (AGZ): Revenue of ₹19 crores in Q1 (1.3x YoY) with QoQ moderation from Q4 peak. ARR trending to ₹120 crores with ₹10 crores monthly run-rate in July. D2C conversion improved from 2% to 3.5%; ROAS improved to 2.0 exit. Onboarded Anupam Kher as brand ambassador; launched on quick commerce (Blinkit, Zepto). Offline channel achieved record ₹5 crores revenue, +18% QoQ. CM2 improving toward breakeven; targeting contribution-positive by Q4 FY27.
Antara Integrated Wellness Clinic (AIWC): Pilot in Gurgaon care home generating ₹15.75 lakhs net revenue with 96% customer satisfaction. Integrating Ayurveda, ozone therapy, infrared sauna, and nutrition around modern medicine. Expected to scale with marketing investment and launch at Antara Noida as residents move in.
Company-Specific & Strategic Commentary
Balanced Capital Light Growth Model: Senior living model is capital-light, tying up with developer partners who own land and construct. AGZ heavy lifting complete; care homes will require majority of incremental capital for expansion. Total capital requirement revised down to under $20 million from $25 million.
Innovation and IP Development: AGZ has 4 granted patents and 3 filed for senior-specific products. Unique adult diaper with smart absorption technology selling 1,500 packs/day with 6x Amazon market share growth. Positioned as key differentiator against competition.
Silver Economy Positioning: Brand recognition growing with Antara Senior Care receiving Visionary Leadership in Senior Living Award. Partnerships with Star Union IIT Life Insurance, IIT Delhi, and Swaasa for wellness integration. Management welcomes DLF's entry into senior living, noting it validates category and increases awareness.
Integrated Care Ecosystem Approach: Strategy focuses on the consumer journey across residences, rehabilitation, diapers, and wheelchairs—the same customer transitioning through different needs based on age and medical condition. AIWC serves as residence differentiator, difficult to replicate.
Guidance & Outlook
| Metric | Guidance / Outlook | Commentary |
|---|---|---|
| AGZ Profitability | Contribution-positive and EBITDA-positive by Q4 FY27 (January onwards) | CM2 improving at marketplaces (-17% in July); ROAS gains and gross margin stability expected to drive breakeven |
| AGZ Revenue Doubling | Revenue from ₹77 crores to ₹150+ crores in FY27 | July ARR at ₹120 crores annualized; Q2-Q4 expected significant top-line improvement with efficient ROAS base |
| Care Home Expansion | New bed additions post October-November inflection point | 5 of 8 care homes trending per operating model; capex ₹10-12 lakhs per bed |
| Senior Living Growth | 1.5 million sq ft per year ambition | Bangalore (₹900 crores value) and Dehradun (₹850-900 crores) opportunities in final diligence stages; disclosure on definitive execution |
| Consolidated Trajectory | Revenue growing substantially with contained EBITDA losses in FY27 | Trajectory of revenue increase (₹175→₹145→₹190 crores) and EBITDA loss containment (₹57→₹139→₹121) expected to continue; management promises visible quarterly improvement |
| Gurgaon 361 Sales Velocity | Normalized post Q1 geopolitical sluggishness | July sold 34 units vs 27 in full Q1; similar trend continuing in August |
Risks & Constraints
| Risk | Context |
|---|---|
| Geopolitical / Logistics Disruption | Ships unavailable for material from China, pushing up logistics costs and COGS; company airlifted some products, depressing margins. Inventory days under pressure; management deploying capital prudently but risk persists. |
| Labor Cost Inflation | Labor courts pushed up manpower costs for the quarter; management seeking mitigation measures. |
| AGZ Seasonality & Concentration | Revenue inherently non-linear with festive and winter peaks; Q4 typically highest due to marketplace year-end deals. D2C repeat rate currently 10-12% (88,000 of 9 lakh customers) with cross-sell identified as key growth lever. |
| Competitive Entry (DLF) | DLF announced senior living entry with 1-2 towers in existing Gurgaon township, tied up with Vedanta Hospital. Management welcomes competition for category awareness but will monitor sales velocity impact; no impact observed to date. |
| Capital Constraints | Only ~$20 million incremental capital required per revised estimates; fund raise pushed out due to Noida collections and credit lines. Care home expansion requires significant capex (₹10-12 lakhs per bed). |
| Senior Living Project Delays | Previous unwinding of Chandigarh (height clearances after Operation Zindoor) and Bangalore (developer financial issues) highlight execution risk; management emphasizing aggressive expansion announcements. |
Q&A Highlights
Path to Profitability and Segment Trajectory
- Question: What changes by Q4 FY27 for EBITDA breakeven on AGZ and care homes? (Harsh Kundnani, Aionios Alpha)
- Answer: Management's profitability commitment is on AGZ specifically, not the full consolidated business. AGZ CM2 improving from -80/-70% historically to -17% at marketplaces in July; improving ROAS driving contribution margins to breakeven by Q4. Care homes require 8-10 quarters per bed to reach unit profitability. (Rajit Mehta, Ajay Agarwal)
- Question: Is blended RPOB of ₹6,500-7,000 correct for care homes? (Harsh Kundnani)
- Answer: Should be near ₹7,500. (Ajay Agarwal)
Revenue Recognition and Reconciliation
- Question: How is Noida ₹169 crores collection recognized, and can you reconcile residence revenue components? (Nikhil Gupta, Vayu Capital)
- Answer: Noida revenue recognized only on possession/registration in Q2, not on collection. Residences have 3 income components: DM fees (
₹7 crores), operations revenue (₹6-7 crores), and finance lease income (~₹15 crores from re-leases in Dehradun, treated as exceptional since not planned). Treasury income accounts for ~₹8 crores. (Rajit Mehta)
AGZ Growth Trajectory and Consumer Metrics
- Question: Is doubling AGZ revenue still achievable given weak Q1? (Nikhil Gupta)
- Answer: Yes, on plan. July ARR at ₹120 crores annualized with ₹10 crores monthly run-rate. Q2-Q4 will see significant top-line improvement backed by strong CM2 and ROAS base. (Ishaan Khanna)
- Question: How much of Q4 peak was seasonal vs pulled forward, and what repeat rate would indicate structural brand strength? (Ranodeep S., MAS Capital)
- Answer: Festive and winter seasonality plus marketplace year-end deals drive Q4 peaks; expected to repeat this year. Repeat rate is 10-12% with 88,000-90,000 repeat customers; same-product repeat is naturally lower for durables like BP monitors—cross-sell is the opportunity. Directionally, 20%+ repeat rate would be good. (Ishaan Khanna, Rajit Mehta)
Competitive Moat and Capital Allocation
- Question: What prevents large hospital chains or developers from entering senior care and compressing returns? (Ranodeep S.)
- Answer: Senior living's core is services IP, not infrastructure—engagement, wellness integration, mental health practices. Real estate players typically outsource healthcare, which isn't sustainable. Hospitals have different profit signatures (30%+ margins vs 18% care home margins) and competencies. AGZ moat is patents on differentiated senior-specific products and brand. (Rajit Mehta)
- Question: Which business generates highest return on capital, and where will incremental capital go? (Rajveer Singh, Vivek Investment Managers)
- Answer: By nature, AGZ will be highest RoCE followed by care homes (23-24% RoCE); ASL is IRR-based with annuity income objective from ₹1,800 crores annual sales value targeting healthy annuity income in '30 and '33. Care home expansion will consume majority of capital. (Rajit Mehta)
Capital Requirements and Competitor Entry
- Question: How will the company sustain with limited cash and losses? (Vikas, Private Investor)
- Answer: Second fund raise originally planned for June 2026 was pushed out due to better performance, credit lines for working capital, ₹40 crores second tranche of pref issue received in July, and Noida possession collections. Total capital requirement has come down from ~$25 million peak to under $20 million. (Rajit Mehta)
- Question: Thoughts on DLF entering senior living? (Rajveer Singh)
- Answer: DLF's entry involves 1-2 towers within existing Gurgaon township with Vedanta Hospital partnership; launch delayed twice over six months and not yet impacted our sales velocity. Competition welcomed for category awareness and potential government standards that would benefit specialized players. (Rajit Mehta)
AIWC Strategic Role
- Question: Will Integrated Wellness Clinic become significant P&L contributor in 3-5 years? (Nikhil Gupta)
- Answer: AIWC is an integral differentiator for residences, not a standalone clinic business. Will be deployed across all residences and care homes as OPDs to attract footfalls. Revenue difficult to predict, but differentiator is comprehensive protocol-based integrated medicine system. (Rajit Mehta)
Key Takeaway
Max India Limited delivered a strong Q1 FY27 with consolidated revenue up 66% YoY to ₹68.6 crores, while EBITDA loss widened to ₹25 crores largely due to lumpy DMP timing and elevated brand spending. The quarter marked a pivotal inflection with possession offered to all 340 Antara Noida residents, unlocking ₹169 crores in collections (75% received) and setting up Phase 2 profit realization at significantly higher pricing (₹16,000-18,000+ per sq ft vs ₹7,000-11,000 Phase 1). Care home occupancy improved sharply across Bannerghatta (41%), Gurugram (41%), Whitefield (18%), and OMR (12%), with 5 of 8 centers trending per model ahead of planned October-November expansion. AGZ revenue grew 1.3x YoY to ₹19 crores with ARR trending toward ₹120 crores, ROAS improving to 2.0, and CM2 at marketplaces narrowing to -17%—management remains committed to AGZ profitability by Q4 FY27. Growth pipeline includes Bangalore (₹900 crores value) and Dehradun (₹850-900 crores) opportunities in final diligence. Management revised total capital requirement down to under $20 million, pushing out fund raise on better performance and Noida collections. Key watch points remain geopolitical logistics disruptions pressuring margins, AGZ seasonality concentration, and competitive entries like DLF—though management welcomes category validation and remains confident of demonstrating quarterly progress toward profitability across all businesses.